1. Korean Diabetes Association. Diabetes. 5th ed. Seoul: PanMun; 2018.
2. Bahar A, Makhlough A, Yousefi A, Kashi Z, Abediankenari S. Correlation between prediabetes conditions and microalbuminuria.
Nephrourol Mon 2013;5(2):741-744.
3. Markus MRP, Ittermann T, Baumeister SE, Huth C, Thorand B, Herder C, et al. Prediabetes is associated with microalbuminuria, reduced kidney function and chronic kidney disease in the general population The KORA (Cooperative Health Research in the Augsburg Region) F4-Study.
Nutr Metab Cardiovasc Dis 2018;28(3):234-242.
4. Kim CH, Kim KJ, Kim BY, Jung CH, Mok JO, Kang SK, et al. Prediabetes is not independently associated with microalbuminuria in Korean general population: the Korea National Health and Nutrition Examination Survey 2011-2012 (KNHANES V-2,3).
Diabetes Res Clin Pract 2014;106(2):e18-e21.
5. Kee YK, Han SH. Recent updates on diabetic nephropathy.
J Korean Diabetes 2017;18(4):214-228.
6. Seo MH, Jee Y, Yoo BW, Hong SH, Cho CY, Cho YJ, et al. Relationship between body mass index and microalbuminuria in healthy adults.
Korean J Fam Pract 2018;8(1):80-86.
9. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease.
Hypertension 2000;35(4):898-903.
10. Bianchi S, Bigazzi R, Campese VM. Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications.
Am J Kidney Dis 1999;34(6):973-995.
11. Colosia AD, Palencia R, Khan S. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review.
Diabetes Metab Syndr Obes 2013;17(6):327-338.
14. Kramer H, Reboussin D, Bertoni AG, Marcovina S, Lipkin E, Greenway FL 3rd, et al. Obesity and albuminuria among adults with type 2 diabetes: the Look AHEAD (Action for Health in Diabetes) Study.
Diabetes Care 2009;32(5):851-853.
16. Won JC, Lee YJ, Kim JM, Han SY, Noh JH, Ko KS, et al. Prevalence of and factors associated with albuminuria in the Korean adult population: the 2011 Korea National Health and Nutrition Examination Survey.
PLoS One 2013;8(12):e83273.
18. Kodama K, Tojjar D, Yamada S, Toda KJ, Patel CJ, Butte A. Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis.
Diabetes Care 2013;36(6):1789-1796.
19. Lee YJ, Lim HJ, Park SI. Characteristics of non-obese diabetes in Korean population. Public Health Weekly Report 2017;10(30):780-787.
20. Eckel N, Mühlenbruch K, Meidtner K, Boeing H, Stefan N, Schulze MB. Characterization of metabolically unhealthy normal-weight individuals: risk factors and their associations with type 2 diabetes.
Metabolism 2015;64(8):862-871.
21. World Health Organization. The Asia-Pacific perspective : redefining obesity and its treatment [Internet]. Sydney: World Health Organization, Regional Office for the Western Pacific; 2000;Accessed Oct 11, 2019]. Available from:
https://apps.who.int/iris/handle/10665/206936
22. Stefan N, Schick F, Häring HU. Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans.
Cell Metab 2017;26(2):292-300.
23. Park J, Ahmadi SF, Streja E, Molnar MZ, Flegal KM, Gillen D, et al. Obesity paradox in end-stage kidney disease patients.
Prog Cardiovasc Dis 2014;56(4):415-425.
24. Wu S, Dong K, Wang J, Bi Y. Tumor necrosis factor alpha improves glucose homeostasis in diabetic mice independent with tumor necrosis factor receptor 1 and tumor necrosis factor receptor.
Endocr J 2018;65(6):601-609.
25. Panahi MH, Hadaegh F, Yavari P, Kazempour-Ardebili S, Mehrabi Y, Azizi F, et al. A Challenging interaction of chronic kidney disease with other metabolic disorders: paradoxes in cardiometabolic risk factors.
Iran J Kidney Dis 2016;10(5):274-281.
26. Rhee CM, Ahmadi SF, Kalantar-Zadeh K. The dual roles of obesity in chronic kidney disease: a review of the current literature.
Curr Opin Nephrol Hypertens 2016;25(3):208-216.
27. Belhatem N, Mohammedi K, Rouzet F, Matallah N, Al Baloshi A, Travert F, et al. Impact of morbid obesity on the kidney function of patients with type 2 diabetes.
Diabetes Res Clin Pract 2015;108(1):143-149.
28. Wang Y, Chen X, Song Y, Caballero B, Cheskin LJ. Association between obesity and kidney disease: a systematic review and meta-analysis.
Kidney Int 2008;73(1):19-33.